Navigation Links
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Date:7/22/2010

program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application in December 2009, and has a Prescription Drug User Fee Act (PDUFA) goal date of October 11, 2010.  In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada.  For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs.  The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements.  These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, and the Company's other Periodic and Current Reports filed with the Securi
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza to Announce 2010 Second Quarter Financial Results on Monday, July 26, 2010
2. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
3. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
4. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
5. Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference
6. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
7. Alexza Pharmaceuticals Files Shelf Registration Statement
8. Alexza to Announce 2010 First Quarter Financial Results on Monday, May 10, 2010
9. Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
10. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
11. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... YORK , July 30, 2014 ACCESS ... for oncology supportive care, announced that its novel product ... in an article on OncLive.com titled, "Study Finds Mouth ... Cancers."  Dr. Steve Sonis , a leading expert ... seen in the oncology community for evidence-based strategies for ...
(Date:7/30/2014)... , July 30, 2014   Bluegrass ... focused on innovating lifesaving devices and methods for ... million in Series A financing, which was led ... from the deal will allow Bluegrass Vascular to ... Catheter System, enhance manufacturing capabilities, and proceed with ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... Dilon expands its portfolio of breast imaging solutions ... Mammography Information System technology by KLAS for three ... loyalty are the foundation of PenRad,s success. Together ... and an information management system that significantly improves ...
... Hurricane Irene came rushing up the East Coast as a ... United States, many states in the Northeast began to worry. The ... hurricanes. Coastal towns from New Jersey all the way up to ... City was one that took steps that had not been seen ...
Cached Medicine Technology:Dilon Diagnostics® Partners With PenRad® 2Dilon Diagnostics® Partners With PenRad® 3Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter 2
(Date:7/30/2014)... July 30, 2014 Hamilton Facial ... of its new Carmel office on July 30th. After ... finally be moving to the state-of-the-art suite, located only ... innovative space will allow for one-on-one patient comfort, shorter ... experience. , Dr. Hamilton’s new office-suite will continue ...
(Date:7/30/2014)... DRE Medical — a leading medical ... of its Medical Trade Shows & Conventions Calendar ... and equipment vendors. , The calendar is a continually-updating ... United States and around the world. Hundreds of entries ... is always growing. , Information listed on each trade ...
(Date:7/30/2014)... The Technology Association of Georgia in collaboration with ... issued its final call for applications and nominations for ... until August 29th 2014 to be considered for this ... the Excalibur Judging Committee. Companies selected as semi-finalists will ... interviewing process. , The TAG Excalibur Awards recognize ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help ... Instant Quote tool on its website, LTCconsumer.com , announced ... are free and unlimited. , The Instant Quote tool ... including age, gender, and state of residence – and delivers ... to enter any contact information to get started). There is ...
(Date:7/30/2014)... July 30, 2014 Children’s Hospital of ... Safety Day from 4 p.m. to 7 p.m. Wednesday, ... 7 Mile Road, Livonia, MI 48152). The event will ... helmets, children’s activities, music, snacks and local public safety ... the Children’s Hospital of Michigan Foundation. , The ...
Breaking Medicine News(10 mins):Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4
... -- About 14 percent of strokes happen while people are ... to the hospital in time for a potentially brain-saving treatment, ... for ischemic stroke must be given within a few hours ... stroke symptoms often can,t receive the treatment since we can,t ...
... new to adolescents, researchers and physicians at Nationwide Children,s ... that is raising some concern among medical professionals. Often ... form of self-injurious behavior that involves inserting foreign objects ... into muscle. A recent study, published in the June ...
... prevalence of overall cardiovascular risk in the Spanish working population ... (8% on men and 2% in women). This prevalence increases ... farming sector, followed by construction, industry and services. "In ... of cardiovascular risk, but only a minority of these people ...
... ROCHESTER, Minn. - Constipation is definitely not a glamorous ... and costs more than $1 billion annually to evaluate ... bloating, discomfort, and straining associated with constipation lead sufferers ... researchers recently had success in the clinical trial of ...
... By Steven Reinberg HealthDay Reporter , MONDAY, May ... associated with a lethal nervous system disease known as amyotrophic ... explain, however, that this does not mean people with long ... they are at higher risk for it. "We have ...
... of U.S. veterans ages 70 and older finds that the ... methods. However, for many less healthy veterans the burdens of ... we really need to target screening in older adults, so ... while those who won,t benefit aren,t exposed to unnecessary burdens," ...
Cached Medicine News:Health News:Research Suggests 1 in 7 Strokes Happens During Sleep 2Health News:A new study on self-injury behavior encourages quick and targeted intervention 2Health News:6 percent of Spanish workers have high cardiovascular risk 2Health News:Mayo Clinic researchers find new treatment for constipation 2Health News:Ring Finger Length Linked to ALS, Study Suggests 2Health News:Ring Finger Length Linked to ALS, Study Suggests 3Health News:Blood test for colon cancer screening beneficial for some seniors, but not for many others 2
... premium product for acne, XtremeClear, powered ... on a scalable multi-application platform. A ... acne, XtremeClear works fast, providing noticeable ... treatments. Uncompromising safety in each of ...
... SpaTouch was designed specifically to meet the varying ... is a simple to use, compact, dual application ... lucrative field of light based hair removal. SpaTouch ... is safe for use on nearly all face ...
... all of the benefits and functionality ... the additional feature of being able ... scanner for importing and storage of ... images. This additional feature allows for ...
Inquire...
Medicine Products: